Ensuring success in working with apheresis centers

Cell & Gene Therapy Insights 2023; 9(2), 141–146

DOI: 10.18609/cgti.2023.019

Published: 2 March 2023
Suzanne Kamps

David McCall, Commissioning Editor, BioInsights, talks to Suzanne Kamps, Associate Director,
Apheresis Operations, Adaptimmune

Suzanne Kamps, BSN RN, currently serves as the Associate Director of Apheresis Operations at Adaptimmune Therapeutics. Suzanne provides expert oversight guiding the procurement of starting material for Adaptimmune’s clinical trials. In her previous role at the Children’s Hospital of Philadelphia, she was a Safety Quality Specialist for Apheresis, responsible for onboarding clinical and commercial cell therapies at their Apheresis Center. In addition, she maintained compliance with regulatory standards to ensure uninterrupted accreditation of the Apheresis Center. She is a Registered Nurse with over 10 years of experience treating Oncology and Apheresis patients.